MDxHealth SA ADR

$ 0.54

-7.62%

12 Jun - close price

  • Market Cap 27,849,800 USD
  • Current Price $ 0.54
  • High / Low $ 0.60 / 0.54
  • Stock P/E N/A
  • Book Value -0.39
  • EPS -0.65
  • Next Earning Report 2026-08-04
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.06 %
  • ROE -24.40 %
  • 52 Week High 5.33
  • 52 Week Low 0.51

About

MDxHealth SA is a pioneering biotechnology company dedicated to advancing precision diagnostics in cancer management, primarily targeting prostate and bladder cancers. Its flagship product, ConfirmMDx for Prostate Cancer, has garnered significant attention for its clinical efficacy and strong market presence. With the increasing emphasis on personalized medicine and the rising demand for targeted cancer therapies, MDxHealth is well-positioned to expand its innovative diagnostic offerings, aiming to meet critical unmet needs in oncology and enhance patient outcomes while pursuing sustainable growth.

Analyst Target Price

$2.90

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-132026-02-262025-11-122025-08-142025-05-142025-02-262024-11-062024-08-212024-05-012024-03-062023-11-072023-08-23
Reported EPS -0.17-0.17-0.16-0.14-0.19-0.14-0.4-0.42-0.31-0.39-0.4-0.3
Estimated EPS -0.098-0.1251-0.17-0.12-0.13-0.19-0.25-0.26-0.3-0.11-0.19-0.22
Surprise -0.072-0.04490.01-0.02-0.060.05-0.15-0.16-0.01-0.28-0.21-0.08
Surprise Percentage -73.4694%-35.8913%5.8824%-16.6667%-46.1538%26.3158%-60%-61.5385%-3.3333%-254.5455%-110.5263%-36.3636%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-08-04
Fiscal Date Ending 2026-06-30
Estimated EPS -0.1
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi